Michael Kauffman, Director at Kezar Life Sciences, Inc. (KZR), sold 5,000 shares at $16.45 ($82K) on 2022-01-03, disclosed to the SEC on 2022-01-05.
Open-market sale of $82k KZR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2022-03-02 | $128K | — | Filing → |
| KPTI | SELL | 2022-02-22 | $440K | — | Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |